Literature DB >> 23196564

[Abnormal plasticity and drug effect in Parkinson's disease].

Hiroyuki Enomoto1, Yoshikazu Ugawa.   

Abstract

The repetitive transcranial magnetic stimulation (rTMS) has been studied as a method to induce plasticity changes in the human brain. And rTMS is expected as a therapeutic tool for Parkinson's disease, depression, intractable pain and others. We reported a new rTMS protocol, quadripulse stimulation (QPS), is more effective. QPS consists of repeated trains of four monophasic TMS pulses separated by inter-stimulus intervals of 5 ms (QPS-5) and 50 ms (QPS-50), inducing bidirectional motor cortical plasticity in an ISI dependent. QPS-5 leads to the potentiation effect. QPS-50 leads to a depression effect. We investigated the changes of plasticity induced by QPS in patients with Parkinson's disease and the healthy volunteer with oral administration of levodopa. In patients with Parkinson's disease the effect of QPS-5 and QPS-50 was attenuated at Off period. However, when the On period it was recovered. In healthy subjects, effect of QPS was enhanced by levodopa, both QPS-5 and QPS-50.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196564     DOI: 10.5692/clinicalneurol.52.1204

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  3 in total

1.  Effects of L-Dopa and pramipexole on plasticity induced by QPS in human motor cortex.

Authors:  Hiroyuki Enomoto; Yasuo Terao; Suguru Kadowaki; Koichiro Nakamura; Arata Moriya; Setsu Nakatani-Enomoto; Shunsuke Kobayashi; Akioh Yoshihara; Ritsuko Hanajima; Yoshikazu Ugawa
Journal:  J Neural Transm (Vienna)       Date:  2015-02-07       Impact factor: 3.575

Review 2.  Quadripulse stimulation (QPS).

Authors:  Hideyuki Matsumoto; Yoshikazu Ugawa
Journal:  Exp Brain Res       Date:  2020-03-24       Impact factor: 1.972

Review 3.  Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson's Disease.

Authors:  Benito de Celis Alonso; Silvia S Hidalgo-Tobón; Manuel Menéndez-González; José Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Neurol       Date:  2015-07-03       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.